Platinum Lecture Series

Highlights of the Best Posters at EAU 2019 – Focus on Next Generation Sequencing

Vladimir Mouraviev, MD, PhD, will soon become the section editor of Grand Rounds in Urology’s soon-to-be released Next Generation Learning Center in Microbials. The European Association of Urology (EAU) will honor Dr. Muraviev this weekend during their annual meeting. The EAU has accepted two of his posters to present during their Expert-Guided Poster Tour session.

Read More

The Value of Life

John M. Barry, MD, Professor of Urology at Oregon Health & Science University, shares the insights from his life and tenure as a urologic surgeon that he has found most helpful and valuable. He gives his perspective on values, impactful books, principles, character, parenting, careers, time, decisions, change, and death in this presentation.

Read More

Management of Nocturia: An Unmet Need in LUTS

Kevin T. McVary, MD, illustrates that while nocturia is the leading lower urinary tract symptom (LUTS) complaint that prompts men to seek out urological care, the condition persists without improvement in 50% of patients, even after treatment. Therefore, there is a significant unmet need in nocturia management practices. He discusses the condition’s financial and quality of life (QOL) burdens, its multifactorial etiology, and his perspective on treatment approaches.

Read More

Reversing the Downward Spiral of Aging

Fred Bartlit, a renowned trial lawyer with 60 years of experience, explains the science behind exercising to combat sarcopenia. During this discussion with E. David Crawford, MD, he summarizes the main points of his book Choosing the StrongPath: Reversing the Downward Spiral of Aging.

Read More

SpaceOAR Hydrogel – Prostate-Rectum Spacing in Radiation Therapy

Lawrence I. Karsh, MD, FACS, discusses the use of SpaceOAR Hydrogel to reduce risk of rectal complications and improve quality of life (QOL) outcomes when treating prostate cancer with radiation therapy. He summarizes supporting clinical evidence, describes the physical application of the gel, and lists players currently offering coverage for the procedure.

Read More

M0 Space and The SPARTAN Trial

Eric J. Small, MD, defines nonmetastatic castration-resistant prostate cancer, or M0 disease. He then discusses the design, implementation, and results of the SPARTAN trial, which he presented at the 2018 Genitourinary Cancers Symposium. The study tested the efficacy of apalutamide in men with M0 disease.

Read More

Join the GRU Community

- Why Join? -